Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 152309100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Avoro Capital Advisors LLC
13G/A
|
7.4% |
5/15/2026
Event 3/31/2026
|
||
| Avoro Capital Advisors LLC | 7.4% | |||
| Behzad Aghazadeh | 7.4% | |||
|
General Atlantic Cooperatief U.A.
13D/A
|
5.0% |
11/28/2025
Event 11/25/2025
|
||
| General Atlantic Cooperatief U.A. | 5.0% | |||
| General Atlantic UM B.V. | 5.0% | |||
| General Atlantic Partners (Bermuda) IV, L.P. | 5.0% | |||
| General Atlantic Partners (Bermuda) EU, L.P. | 5.0% | |||
| General Atlantic Partners (Lux) SCSp | 5.0% | |||
| General Atlantic GenPar (Lux) SCSp | 5.0% | |||
| General Atlantic (Lux) S.a r.l. | 5.0% | |||
| General Atlantic GenPar (Bermuda), L.P. | 5.0% | |||
| GAP (Bermuda) Limited | 5.0% | |||
| General Atlantic Cooperatief, L.P. | 5.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
FMR LLC
13G/A
|
0% |
7/8/2026
Event 6/30/2026
|
||
| FMR LLC | 0% | |||
| Abigail P. Johnson | 0% | |||
|
Adage Capital Management, L.P.
13G/A
|
0% |
8/12/2026
Event 6/30/2026
|
||
| Adage Capital Management, L.P. | 0% | |||
| Robert Atchinson | 0% | |||
| Phillip Gross | 0% | |||
|
Farallon Capital Management, L.L.C.
13D/A
|
0% |
6/26/2026
Event 6/24/2026
|
||
| Farallon Capital Management, L.L.C. | 0% | |||
| Dapice Joshua J. | 0% | |||
| Dreyfuss, Philip D. | 0% | |||
| Dunn Hannah E. | 0% | |||
| Gehani, Varun N. | 0% | |||
| Giauque, Nicolas | 0% | |||
| Husen, Avner A. | 0% | |||
| Kim, David T. | 0% | |||
| Linn, Michael G. | 0% | |||
| Luo Patrick (Cheng) | 0% | |||
| Roberts, Jr., Thomas G. | 0% | |||
| Saito Edric C. | 0% | |||
| Short Daniel S. | 0% | |||
| Spokes, Andrew J. M. | 0% | |||
| Warren, John R. | 0% | |||
| Wehrly, Mark C. | 0% | |||
|
Index Ventures Life VI (Jersey) L.P.
13G/A
|
0% |
8/14/2026
Event 6/30/2026
|
||
| Index Ventures Life VI (Jersey) L.P. | 0% | |||
| Yucca (Jersey) SLP | 0% | |||
| Index Venture Life Associates VI Ltd | 0% | |||
|
Medicxi Growth I LP
13G/A
|
0% |
8/4/2026
Event 6/30/2026
|
||
| Medicxi Growth I LP | 0% | |||
| Medicxi Growth Co-Invest I LP | 0% | |||
| Medicxi Growth I GP Limited | 0% | |||
| Medicxi Ventures I LP | 0% | |||
| Medicxi Co-Invest I LP | 0% | |||
| Medicxi Ventures I GP Limited | 0% | |||
| Medicxi Secondary I LP | 0% | |||
| Medicxi Secondary Co-Invest I LP | 0% | |||
| Medicxi Secondary I GP Limited | 0% | |||
| Medicxi Ventures Management (Jersey) Limited | 0% | |||
|
Pentwater Capital Management LP
13G/A
|
0% |
8/14/2026
Event 6/30/2026
|
||
| Pentwater Capital Management LP | 0% | |||
| Matthew Halbower | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 177 | 149 M | $5.90 B |
| 2025 Q4 | 160 | 144 M | $3.60 B |
| 2025 Q3 | 143 | 129 M | $3.12 B |
| 2025 Q2 | 129 | 124 M | $1.62 B |
| 2025 Q1 | 144 | 125 M | $1.80 B |
| 2024 Q4 | 119 | 124 M | $2.08 B |
| 2024 Q3 | 109 | 109 M | $1.74 B |
| 2024 Q2 | 87 | 89.0 M | $804 M |
| 2024 Q1 | 76 | 78.7 M | $889 M |
| 2023 Q4 | 65 | 72.5 M | $577 M |
| 2023 Q3 | 53 | 72.6 M | $470 M |
| 2023 Q2 | 48 | 70.3 M | $435 M |
| 2023 Q1 | 45 | 66.9 M | $258 M |
| 2022 Q4 | 46 | 63.9 M | $233 M |
| 2022 Q3 | 46 | 74.8 M | $300 M |
| 2022 Q2 | 42 | 71.8 M | $350 M |
| 2022 Q1 | 46 | 74.6 M | $670 M |
| 2021 Q4 | 49 | 71.9 M | $808 M |
| 2021 Q3 | 41 | 56.9 M | $947 M |
| 2021 Q2 | 51 | 47.4 M | $1.05 B |